Iterum Therapeutics PLC
ITRM
Mkt cap
$38.56M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2025-09-30)
$390,000
EPS (9mo ended 2025-09-30)
$-0.51
Gross Margin (qtr ended 2025-09-30)
N/A
Profit Margin (qtr ended 2025-09-30)
-2302.31%
Beta
2.82
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$9.0M. Revenue was up 954.1% from 2019-09-30 to 2025-09-30. ITRM currently screens at market cap $38.6M.
Use this ITRM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ITRM income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Iterum Therapeutics PLC (ITRM) is a biotechnology company in the Healthcare sector.
Latest cached Iterum Therapeutics PLC (ITRM) revenue for Sep 30, 2025 was $390.0K. Net income was -$9.0M. Statements: https://lician.com/financials/itrm
Iterum Therapeutics PLC (ITRM) market capitalization is $38.6M on the latest cached snapshot.